Category: Industry Press Releases

One-Year Results from Real-World Study Showed Abbott’s Portico™ Transcatheter Aortic Valve Safely and Successfully Reduced Severe Aortic Stenosis

September 25, 2018

“Abbott (NYSE: ABT) today announced one-year results from a real-world, international, multicenter, 941-patient study of the company’s Portico™ transcatheter aortic valve replacement (TAVR) system in patients with symptomatic, severe aortic stenosis – a life-threatening narrowing of the heart’s aortic valve.”

Visit Website

Landmark Study Shows Treatment with Abbott’s MitraClip® is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation

September 23, 2018

“Abbott (NYSE: ABT) today announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip® device to guideline-directed medical therapy in select patients with secondary (or functional) mitral regurgitation, or a leaky heart valve, as a result of advanced heart failure.”

Visit Website
Page 1 of 1112345...10...»